Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
DKSH’s Business Unit Consumer Goods further capitalizes on its position to strengthen the consumer health, nutrition, and baby care categories
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
The Issue opened on June 18, 2024 and closed on June 21, 2024
Cipla had earlier invested € 15 million in Ethris in 2022
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Subscribe To Our Newsletter & Stay Updated